| | |||||
| Ebola | |||||
| NEWS | |||||
| After Ebola success, Regeneron turns antibody capabilities against 2019-nCoV Regeneron has previously applied its antibody discovery capabilities to pathogens including Ebola and Middle East respiratory syndrome coronavirus ...
| |||||
| As the deadly coronavirus continues to spread, at what point does it become a pandemic? "So far, more than 1 billion U.S. dollars has been spent trying to stop the Ebola outbreak in DRC. By comparison, just 18 million dollars was spent on ...
| |||||
| Last Week, the World Health Organization Declared Coronavirus a Global Health Emergency ... In the 15 years since, it's been used only five other times, including two outbreaks—Ebola in Democratic Republic of the Congo and polio in Pakistan, ...
| |||||
| Mid-valley med centers prepared for coronavirus After the international Ebola outbreak in 2014, Samaritan developed the Northwest Biopreparedness Training Center at its Lebanon hospital, where ...
| |||||
| US working with pharmaceutical firm on new type of coronavirus treatment Regeneron's REGN-EB3, a cocktail of three monoclonal antibodies, was last year shown to significantly boost survival rates among Ebola patients in ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar